RxDoctor Payments DataLook up a doctor →

Steven Schechter, MD

Neurology · West Bloomfield, MINPI 1902897390

Payments from drug & device makers

$166,228in general payments, 2019–2025

Across 1,666 payments — averaging $99.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • MDD US Operations, LLC$40K
  • Sanofi$25K
  • Lilly USA, LLC$16K
  • EMD Serono, Inc.$14K
  • AbbVie$14K
  • Bristol Myers Squibb$10K
  • plus $48K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
MDD US Operations, LLC84$39,630
Sanofi63$25,048
Lilly USA, LLC81$16,063
EMD Serono, Inc.98$13,847
AbbVie(2 entities)84$13,667
Bristol Myers Squibb60$9,939
Corium, LLC22$9,368
Novartis231$8,143
Genentech USA, Inc.30$7,122
UCB, Inc.145$2,591
H. Lundbeck A S2$2,505
Amneal Pharmaceuticals LLC10$1,654
Biogen56$1,556
Neurocrine Biosciences, Inc.56$1,396
Teva Pharmaceuticals USA, Inc.59$1,144
Eisai Inc.36$994
Mallinckrodt Hospital Products Inc.7$863
Alnylam Pharmaceuticals Inc.37$839
SK Life Science, Inc.27$634
Pfizer33$584
Kyowa Kirin, Inc.26$545
TG Therapeutics, Inc.27$514
Lundbeck LLC23$495
Sunovion Pharmaceuticals Inc.28$405
Amgen(2 entities)33$400
Supernus Pharmaceuticals, Inc.19$386
Acorda Therapeutics, Inc20$385
Neurelis, Inc.17$384
Vanda Pharmaceuticals Inc.18$371
AstraZeneca(2 entities)17$329
Harmony Biosciences LLC13$314
Greenwich Biosciences, Inc.10$303
Jazz Pharmaceuticals Inc.14$288
Johnson & Johnson14$248
Acadia Pharmaceuticals Inc12$241
Otsuka America Pharmaceutical, Inc.11$215
Adamas Pharmaceuticals, Inc.13$214
Sumitomo Pharma America, Inc.14$211
Biohaven Pharmaceuticals, Inc.9$177
Upsher-smith Laboratories LLC8$161
Aquestive Therapeutics, Inc.4$160
Argenx US, Inc.7$138
Catalyst Pharmaceuticals, Inc.7$138
Tanabe Pharma America, Inc.5$130
Biohaven Pharmaceutical Holding Company Ltd.7$129
Arbor Pharmaceuticals, Inc.7$123
Banner Life Sciences, LLC5$121
Avanir Pharmaceuticals, Inc.7$111
E.r. Squibb & Sons, L.L.C.5$95
Otter Pharmaceuticals, LLC3$81
Zogenix Inc.3$80
Aucta Pharmaceuticals, Inc.4$78
Zyla Life Sciences, Inc.4$67
ANI Pharmaceuticals, Inc.3$66
Avion Pharmaceuticals3$57
Azurity Pharmaceuticals, Inc.3$49
Akcea Therapeutics, Inc.2$41
CSL Behring2$35
Scilex Pharmaceuticals Inc.2$33
Ironshore Pharmaceuticals Inc.1$28

How this compares

$166,228 in reported general payments places this provider in the 90th percentile of 652 neurology providers in Michigan.

See all neurology providers in Michigan

Medicare billing

Part B allowed, 2024
$121,520
Medicare patients
342
Services billed
826

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in West Bloomfield

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →